期刊文献+

真菌耐药的现状与对策 被引量:13

Current situation of and countermeasures to antifungal agent resistance
暂未订购
导出
摘要 真菌耐药的报道日益增多,目前的研究一方面进一步探讨真菌产生耐药的机制、传播方式、耐药性与临床治疗的关系,以及建立标准化抗真菌药物敏感试验,从而控制耐药性的进一步发展;另一方面加快开发新的抗真菌药物,以应对日益增多的耐药真菌。 Reports of antifungal agent resistance have increased in recent years. On one hand, the current research has been focused on relations between mechanism of drug resistance, mode of transmission,drug resistance and clinical therapy,and the standard antifungal susceptibility test for controlling further progress of drug resistance has been established. On the other hand,measures are being taken to accelerate development of the new antifungal agents to cope with increased drug resistance.
出处 《药学服务与研究》 CAS CSCD 2006年第3期161-164,共4页 Pharmaceutical Care and Research
关键词 抗真菌药 抗药性 真菌 综述 antifungal agents drug resistance, fungal review
  • 相关文献

参考文献12

  • 1RYLEY J F,WILSON R G,BARRETT-BEE K J.Azole resistance in Candida albicans[J].Sabouraudia,1984,22(1):53-63.
  • 2CASALINUOVO I A,DI FRANCESCO P,Garaci E.Fluconazole resistance in Candida albicans:a review of mechanisms[J].Eur Rev Med Pharmacol Sci,2004,8(2):69-77.
  • 3VARGAS K,MESSER S A,PFALLER M,et al.Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode[J].J Clin Microbiol,2000,38 (10):3595-3607.
  • 4PERFECT J R.Antifungal resistance:the clinical front[J].Oncology (Williston Park),2004,18(14 Suppl 13):15-22.
  • 5HILLER D,SANGLARD D,MORSCHHAUSER J.Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans[J].Antimicrob Agents Chemother,2006,50(4):1365-1371.
  • 6NIIMI M,NIIMI K,TAKANO Y,et al.Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance[J].J Antimicrob Chemother,2004,54 (6):999-1006.
  • 7JHA S,DABAS N,KARNANI N,et al.ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry[J].FEMS Yeast Res,2004,5(1):63-72.
  • 8SAMARANAYAKE Y H,YE J,YAU J Y,et al.In vitro method to study antifungal perfusion in Candida biofilms[J].J Clin Microbiol,2005,43(2):818 825.
  • 9孙秋宁,方凯.念珠菌生物膜的结构、影响因素及其对抗真菌药的敏感性[J].中国医学科学院学报,2002,24(4):385-388. 被引量:11
  • 10MORRISON V A.Echinocandin antifungals:review and update[J].Expert Rev Anti Infect Ther,2006,4 (2):325-342.

二级参考文献28

  • 1[1]Wey SB, Mori MA. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med, 1988, 148:2642-2645
  • 2[2]Nguyen MH, Peacock Jr JE. Therapeutic approaches in patients with candidemia:evaluation in a muliticenter, propective, observational study. Arch Intern, 1995, 155:2429-2435
  • 3[3]Odds FC. Candida infections: an overview. Crit Rev Nicrobiol, 1987, 15:1-5
  • 4[4]Crump JA, Colllgnon PJ. Intravascular catheter-assocated infections. Eur J Clin Microbiol Infect Dis, 2000, 19:1-8
  • 5[5]Baillie GS, Douglas LJ. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol, 1999, 310:644-656
  • 6[6]Costerton JW, Stewart PS. Bacterial biofilms: a common cause of persistent infections. Science, 1999, 284:1318-1322
  • 7[7]Ramage GW, Walle KV, Wickes BL, et al. Standa-dized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemcther,2001, 45:2475-2479
  • 8[8]Hawser SP, Norris H, Jessup C J, et al. Comparison of a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl) -5- (phenylamino)carbonyl-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol,1998, 36:1450-1452
  • 9[9]National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast's approved standard. NCCLS Document. M27-A. Wayne, PA (USA) : National Committee for Clinical Laboratory Standards. 1997
  • 10[10]Kuhn DM, Chandra J, Mukher PK, et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Imm, 2002, 70:878-888

共引文献21

同被引文献82

引证文献13

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部